RCUS FY 2025 Earnings — Arcus Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RCUSArcus Biosciences, Inc.

$2B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$247M-4.3% YoY

Gross Profit

$237M96.0% margin

Operating Income

-$386M-156.3% margin

Net Income

-$353M-142.9% margin

EPS (Diluted)

$-3.29

Cash Flow

Operating Cash Flow

-$482M

Free Cash Flow

-$484M

Stock-Based Comp.

$60M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$508M

Stockholders' Equity

$631M

Cash & Equivalents

$222M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$247M	$258M	-4.3%
Gross Profit	$237M	$258M	-8.1%
Operating Income	-$386M	-$330M	-17.0%
Net Income	-$353M	-$283M	-24.7%